Dietary intake and biomarkers of alpha linolenic acid and risk of all cause, cardiovascular, and cancer mortality: systematic review and dose-response meta-analysis …

S Naghshi, D Aune, J Beyene, S Mobarak, M Asadi… - Bmj, 2021 - bmj.com
… Combining data from these studies, comparing the highest and lowest levels of ALA,
indicated no significant association between tissue levels of ALA and CHD mortality (pooled …

[HTML][HTML] Impact of α-linolenic acid, the vegetable ω-3 fatty acid, on cardiovascular disease and cognition

A Sala-Vila, J Fleming, P Kris-Etherton, E Ros - Advances in Nutrition, 2022 - Elsevier
… of fatal coronary heart disease. Three randomized controlled trials (RCTs) [… inverse association
between intake of ALA and the risk of IHD among US men with low LCn–3PUFA intake (<…

Associations of serum nonesterified fatty acids with coronary heart disease mortality and nonfatal myocardial infarction: the CHS (cardiovascular health study) cohort

NK Huang, P Bůžková, NR Matthan… - … Heart Association, 2021 - Am Heart Assoc
… The objective of this study was to assess the relation between serum NEFA subclasses and
CHD (CHD composite, including CHD mortality and nonfatal myocardial infarction [MI]), CHD

[PDF][PDF] Intake of α-linolenic acid is not consistently associated with a lower

CS Bork, AN Lasota, S Lundbye-Christensen… - British Journal of … - pure.au.dk
association between ALA intake and the risk of atherosclerotic CVD have focused on CHD
Some cohort studies have reported inverse associations between ALA intake and CHD risk(…

[HTML][HTML] Dietary intake and biomarkers of linoleic acid and mortality: systematic review and meta-analysis of prospective cohort studies

J Li, M Guasch-Ferré, Y Li, FB Hu - The American journal of clinical nutrition, 2020 - Elsevier
… benefits for the prevention of coronary artery disease (CAD) (… surrounding the relation
between LA intake and mortality risk, … (ie, “fatty acids” or “linoleic acids” or “α-linolenic acids”) and …

[HTML][HTML] Dietary intake and biomarkers of α-linolenic acid and mortality: a meta-analysis of prospective cohort studies

LH Chen, Q Hu, G Li, L Zhang, LQ Qin, H Zuo… - Frontiers in …, 2021 - frontiersin.org
… Though dietary ALA is associated with a reduced risk of fatal CHD, the associations with
other subtypes of CVD are unclear. Moreover, some meta-analyses showed that ALA increased …

Effects of α-linolenic acid intake on blood lipid profiles: a systematic review and meta-analysis of randomized controlled trials

H Yue, B Qiu, M Jia, W Liu, X Guo, N Li… - Critical Reviews in …, 2021 - Taylor & Francis
… , so the main n-3 PUFA source is α-linolenic acid (ALA) from different plants such as … risk
factors in many diseases. The latest randomized controlled trials found no association between n…

[HTML][HTML] … of Essential Fatty Acids, Linoleic and α-Linolenic Acid, in US Adults in 2003–2004 and 2011–2012 and the Relation with Risk Factors for Cardiometabolic …

KS Petersen, VK Sullivan, VL Fulgoni III, F Eren… - Current Developments …, 2020 - Elsevier
… lower risk of CVD, particularly fatal coronary heart disease (9, 10). Evidence for the relation
between … Thus, further investigation of the relation between essential fatty acids and risk of …

[HTML][HTML] Association of Dietary Intake and Biomarker of α-Linolenic Acid With Incident Colorectal Cancer: A Dose-Response Meta-Analysis of Prospective Cohort …

ZB Dai, XL Ren, YL Xue, Y Tian, BB He, CL Xu… - Frontiers in …, 2022 - frontiersin.org
association between ALA intake and the incident colorectal cancer (CRC). We aimed to
investigate the summary association of dietary intake and biomarkers of ALA with CRC risk

Dietary and Circulating Long‐Chain Omega‐3 Polyunsaturated Fatty Acids and Mortality Risk After Myocardial Infarction: A Long‐Term Follow‐Up of the Alpha Omega …

K Pertiwi, LK Küpers, J de Goede, PL Zock… - … Heart Association, 2021 - Am Heart Assoc
… recommendation by the American Heart Association of 1 to 2 … found a 20% lower risk of fatal
CHD for intakes of only 50 to … +DHA intake and long‐term mortality risk in patients with CHD